Seung Hyeok Han (Yonsei University College of Medicine)

1997 B.S. degree, Yonsei Univ. College of Medicine Seoul, Korea

2008 Ph.D. degree in Medical Science, Yonsei University College of Medicine, Seoul, Korea

2017~ Professor (Tenure-track), Division of Nephrology, Yonsei University College of Medicine, Seoul, Korea

2022~ Director of the Institute of Kidney Disease Research, Yonsei University

2024~ Associate editor, Clinical Journal of the American Society of Nephrology

Glomerular disease; Clinical trials; Cardiovascular disease in CKD; Diabetic kidney disease; Nutrition

1. BP and Kidney Disease Progression in Advanced CKD: Findings from the Chronic Renal Insufficiency Cohort and KoreaN Cohort Study for Outcome in Patients with CKD Studies. Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Oh KH, Anderson AH, Yang W, Cohen JB, Rahman M, Kang SW, Han SH; on the behalf of CRIC Study and KNOW-CKD Investigators. Clin J Am Soc Nephrol. 2025;20(9):1179-1189

2. Ethnic Disparities in CKD Progression: A Comparative Study of CRIC and KNOW-CKD Cohorts. Ko B, Jung CY, Ko YE, Kang DH, Heo GY, Koh HB, Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Kang SW, Park SK, Jung JY, Jeong JC, Kim Y, Oh KH, Anderson AH, Yang W, Cohen JB, Rahman M, Han SH; on the behalf of CRIC and KNOW-CKD Investigators. Clin J Am Soc Nephrol. 2026;21(2):229-241.

3. Pyruvate kinase M2 activation maintains mitochondrial metabolism by regulating the interaction between HIF-1α and PGC-1α in diabetic kidney disease. Park J, Joo YS, Nam BY, Kim G, Park JT, Yoo TH, Kang SW, Han SH. Mol Med. 2025;31(1):266.

4. Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial. Perkovic V, Trimarchi H, Tesar V, Lafayette R, Wong MG, Barratt J, Suzuki Y, Liew A, Zhang H, Carroll K, Jha V, Quevedo A, Han SH, Praga M, Chacko B, Sahay M, Cheung CK, Kooienga L, Walsh M, Xia J, Fajardo C, Shah L, Hafkin J, Rizk DV; VISIONARY Trial Investigators Group. N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512133. Online ahead of print.

5. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. Fakhouri F, Bomback AS, Ariceta G, Delmas Y, Dixon BP, Gale DP, Greenbaum LA, Han SH, Isbel N, Le Quintrec M, Licht C, Mastrangelo A, Mizuno M, Neves de Holanda MI, Pickering MC, Remuzzi G, Van De Kar N, Vivarelli M, Walker PD, Wallace D, Zecher D, Francois C, Deschatelets P, Li L, Wang Z, Abad-Franch L, Kinnman N, López-Lázaro L, Szamosi J, Nester CM; VALIANT Trial Investigators Group. N Engl J Med. 2025;393(22):2210-2220.